- Home
- GGAL vs TECH Comparison
GGAL vs TECH Comparison
Compare GGAL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGAL
- TECH
- Stock Information
- Founded
- GGAL 1905
- TECH 1976
- Country
- GGAL Argentina
- TECH United States
- Employees
- GGAL N/A
- TECH N/A
- Industry
- GGAL Commercial Banks
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GGAL Finance
- TECH Health Care
- Exchange
- GGAL Nasdaq
- TECH Nasdaq
- Market Cap
- GGAL 7.1B
- TECH 8.0B
- IPO Year
- GGAL N/A
- TECH 1989
- Fundamental
- Price
- GGAL $61.45
- TECH $50.50
- Analyst Decision
- GGAL Strong Buy
- TECH Buy
- Analyst Count
- GGAL 4
- TECH 8
- Target Price
- GGAL $59.00
- TECH $81.14
- AVG Volume (30 Days)
- GGAL 1.7M
- TECH 2.3M
- Earning Date
- GGAL 01-01-0001
- TECH 05-07-2025
- Dividend Yield
- GGAL 3.86%
- TECH 0.63%
- EPS Growth
- GGAL 120.03
- TECH N/A
- EPS
- GGAL 1.06
- TECH 0.98
- Revenue
- GGAL $6,697,505,438.00
- TECH $1,196,016,000.00
- Revenue This Year
- GGAL $9.54
- TECH $8.19
- Revenue Next Year
- GGAL N/A
- TECH $8.61
- P/E Ratio
- GGAL $6.53
- TECH $51.54
- Revenue Growth
- GGAL N/A
- TECH 4.46
- 52 Week Low
- GGAL $23.53
- TECH $46.44
- 52 Week High
- GGAL $74.00
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- GGAL 56.41
- TECH 41.82
- Support Level
- GGAL $61.67
- TECH $49.15
- Resistance Level
- GGAL $66.24
- TECH $51.53
- Average True Range (ATR)
- GGAL 3.49
- TECH 2.64
- MACD
- GGAL 0.79
- TECH 0.44
- Stochastic Oscillator
- GGAL 81.25
- TECH 54.03
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.